BAM
CELG

Bedlam Asset Management’s Celgene Corp CELG Stock Holding History

Bedlam Asset Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-71,950
Closed -$5.54M – 21
2013
Q3 		$5.54M Sell
71,950
-55,134
-43% -$3.86M 4.4% 12
2013
Q2 		$7.43M Buy
+127,084
New +$7.65M 5.56% 11

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bedlam Asset Management's CELG Position: Q4 2013 in Review

Bedlam Asset Management sold out of Celgene Corp (CELG) in Q4 2013, closing a stake of 71,950 shares — an estimated $5.54M sold.

Bedlam Asset Management first reported a position in CELG in Q2 2013 and held it in 2 quarters. The position peaked at $7.43M in Q2 2013. 983 funds tracked by Wall St. Rank hold CELG as of Q4 2013.

  • Bedlam Asset Management reported no remaining Celgene Corp position as of Q4 2013 after selling out during the quarter.
  • Bedlam Asset Management sold 71,950 Celgene Corp shares in Q4 2013, an estimated $5.54M.
  • Bedlam Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 2 quarters.
  • Bedlam Asset Management's Celgene Corp position peaked at $7.43M in Q2 2013.
  • 983 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2013.

Based on Bedlam Asset Management's 13F filing for Q4 2013.